sp-3164
salarius pharma
['lymphoma', 'sp-3164', 'salarius']
missed our presentations during #ash22? no problem! see the new study data shared by daniela santiesteban, phd, on the significant anti-cancer activity of sp-3164. access the salarius ash 2022 poster here: #lymphoma 
Salarius is a cancer-focused biotechnology company. Currently in clinical trials for Ewing Sarcoma w/ Orphan Drug & Rare Pediatric Disease Designation.